Traditional Chinese Medicine Targeting the Ischemic Cascade in Ischemic Stroke: Multitarget Mechanisms and Therapeutic Potential
European Journal of Neuroscience · 2026-11 · 64 (9)
DOI: 10.1111/ejn.70753 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, online erschienen am 03.11.2026. Verfasst von Yuxiang Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Medicine, Chinese Traditional, Brain Ischemia, Drugs, Chinese Herbal. Die Arbeit nennt 158 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke (IS) remains a major cause of mortality and long‐term disability worldwide. Increasing evidence indicates that injury progression after cerebral ischemia is closely associated with dysfunction of the neurovascular unit (NVU). Following ischemia, a series of interconnected pathological events, including metabolic failure, excitotoxicity, calcium dysregulation, oxidative injury, inflammation and cell death, contribute to progressive neuronal and vascular damage. Traditional Chinese medicine (TCM) has been increasingly investigated as a source of multicomponent interventions for IS. Experimental studies indicate that bioactive compounds, extracts and classical formulas may influence multiple components of the ischemic cascade, including energy metabolism, glutamate excitotoxicity, Ca 2+ homeostasis, oxidative stress, neuroinflammation and regulated cell death. These effects have been associated with pathways including AMPK/SIRT1, PI3K/Akt, Nrf2/HO‐1, NF‐κB and NLRP3. However, modulation of multiple pathways does not necessarily establish pharmacological synergy or superiority over single‐target interventions. This review summarizes TCM interventions targeting the ischemic cascade, with a primary focus on studies published between 2015 and 2025. Particular attention is given to the strength of mechanistic evidence, treatment timing, experimental models, pharmacologically active constituents, safety and clinical translation. By critically evaluating both mechanistic findings and current limitations, this review provides a framework for assessing the evidence and translational potential of TCM‐derived neuroprotective strategies in IS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
- College of Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
ORCID-Profile: Peiliang Dong, Hua Han
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Song, Y., Yang, M., Wang, S., Chen, Y., Dong, P., & Han, H. (2026). Traditional Chinese Medicine Targeting the Ischemic Cascade in Ischemic Stroke: Multitarget Mechanisms and Therapeutic Potential. European Journal of Neuroscience, 64(9). https://doi.org/10.1111/ejn.70753
Vancouver
Song Y, Yang M, Wang S, Chen Y, Dong P, Han H. Traditional Chinese Medicine Targeting the Ischemic Cascade in Ischemic Stroke: Multitarget Mechanisms and Therapeutic Potential. European Journal of Neuroscience. 2026;64(9). doi:10.1111/ejn.70753
BibTeX
@article{Song2026,
author = {Song, Yuxiang and Yang, Meng and Wang, Siwen and Chen, Ying and Dong, Peiliang and Han, Hua},
title = {Traditional Chinese Medicine Targeting the Ischemic Cascade in Ischemic Stroke: Multitarget Mechanisms and Therapeutic Potential},
journal = {European Journal of Neuroscience},
year = {2026},
volume = {64},
number = {9},
doi = {10.1111/ejn.70753}
}
EUVIMED